NFATc1-IN-1 (compound A04) is a potent inhibitor of RANKL-induced osteoclast formation, with an IC50 of 1.57 µM. NFATc1-IN-1 shows anti-osteoclastogenic effects through reducing the RANKL-induced nuclear translocation of NFATc1. NFATc1-IN-1 can be used for osteoclastic diseases research[1].
Molekulargewicht:
375.11
Reinheit:
99.97
CAS Nummer:
[1912422-56-0]
Formel:
C13H8F2INO2
Target-Kategorie:
Nuclear Factor of activated T Cells (NFAT)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten